Contemporary ASD Closure: A Review of FDA-Approved Devices and Patient-Specific Selection-ASD Closure in Adults with Congenital Heart Disease, Dr. Ada C. Stefanescu Schmidt

ASD Closure in Adults with Congenital Heart Disease, Dr. Ada C. Stefanescu Schmidt

Video Transcription

Video Summary

The speaker discusses the considerations and challenges of closing atrial septal defects (ASDs) in adults with congenital heart disease. Emphasizing older adults, they highlight potential comorbidities such as pulmonary hypertension, heart disease, and diastolic dysfunction, which can influence treatment approaches. Innovations include fenestrated devices for specific cases and improving medical therapies for conditions like heart failure. The speaker advises cautious assessment, engaging with heart failure specialists, and possible fluid challenges for accurate diagnosis. They caution against rushing procedures in older adults and stress the importance of optimizing medical management.

Keywords

atrial septal defects

congenital heart disease

pulmonary hypertension

fenestrated devices

medical management